Shares of Ultralife Co. (NASDAQ:ULBI – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $8.33 and traded as high as $13.39. Ultralife shares last traded at $12.66, with a volume of 106,955 shares trading hands.
Analyst Upgrades and Downgrades
A number of analysts have weighed in on ULBI shares. StockNews.com lowered Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, May 2nd. Benchmark boosted their price target on Ultralife from $12.00 to $13.00 and gave the stock a “buy” rating in a research report on Tuesday, March 5th.
Read Our Latest Stock Report on ULBI
Ultralife Stock Down 3.1 %
Ultralife (NASDAQ:ULBI – Get Free Report) last announced its earnings results on Thursday, February 15th. The technology company reported $0.18 earnings per share for the quarter. The company had revenue of $44.55 million during the quarter. Ultralife had a net margin of 6.19% and a return on equity of 10.31%.
Institutional Trading of Ultralife
Several large investors have recently bought and sold shares of ULBI. Empowered Funds LLC increased its position in shares of Ultralife by 7.8% in the 1st quarter. Empowered Funds LLC now owns 31,396 shares of the technology company’s stock valued at $277,000 after acquiring an additional 2,275 shares during the period. Janney Montgomery Scott LLC increased its holdings in shares of Ultralife by 10.0% in the first quarter. Janney Montgomery Scott LLC now owns 439,100 shares of the technology company’s stock valued at $3,868,000 after purchasing an additional 40,000 shares during the period. Visionary Wealth Advisors raised its stake in shares of Ultralife by 0.9% in the fourth quarter. Visionary Wealth Advisors now owns 1,082,246 shares of the technology company’s stock worth $7,381,000 after purchasing an additional 9,997 shares during the last quarter. D.A. Davidson & CO. acquired a new stake in shares of Ultralife during the fourth quarter worth about $163,000. Finally, Navellier & Associates Inc. acquired a new position in Ultralife in the 4th quarter worth approximately $310,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.
About Ultralife
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
See Also
- Five stocks we like better than Ultralife
- How to invest in blue chip stocks
- Roblox: The Bottom Just Fell Out of the Metaverse
- Trading Stocks: RSI and Why it’s Useful
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- 5 discounted opportunities for dividend growth investors
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.